top of page
Precision Neoepitope Discovery
Redefining Precision in Immunopeptidomics
Current workflows can lose up to 99% of tumor immunopeptides.
What if we could capture the vast majority — even from minimal input?
​Or better yet, selectively capture the ones that matter for therapy?
ImmunoEdge Is Unlocking Immune Insights, Including for Rare and Low-Input Cell Populations.
Breakthroughs in Cancer Therapeutics
Breakthroughs require precision, speed, and cutting-edge technology. Our approach extracts deeper molecular insights, accelerating the path to better treatments.
Precision Insights
Our platform enhances resolution by extracting critical details from minimally invasive samples.
Accelerated Therapeutic Pathways
Our streamlined solution eliminates slow, fragmented workflows, accelerating the path from discovery to clinical application.
Unveiling Hidden Targets
Revealing a broader neoantigen landscape expands treatment options.
​
ImmunoEdge is leading the next generation of neoepitope detection, transforming cancer therapeutics and diagnostics. By improving sensitivity, reducing bias, and paving the way for single-cell peptidomics, we enhance target discovery for precision medicine.
bottom of page